Skip to main content
Implanet SA logo

Implanet SA — Investor Relations & Filings

Ticker · ALIMP ISIN · FR0013470168 LEI · 969500CIMHFWNM4J4V14 PA Manufacturing
Open in API
Filings indexed 266 across all filing types
Latest filing 2025-11-13 Regulatory Filings
Country FR France
Listing PA ALIMP

About Implanet SA

http://www.implanet.com/en

Implanet is a medical technology company that designs, manufactures, and markets a range of implants and instruments for orthopedic surgery, with a specialized focus on spinal applications. The company's core offering is centered around its flagship Jazz™ platform, a latest-generation hybrid posterior fixation system intended to improve the treatment of various spinal disorders, including scoliosis. The product portfolio also includes other spinal systems such as Zeus™ and Saxxo™, Swingo™ interbody cages, Origin™ anterior cervical plates, and the Olea™ system for ultrasonic osteotomy. Additionally, Implanet provides complementary solutions like Neobone™ bone grafts. The company's products are utilized by surgeons and healthcare professionals in the field of spinal surgery.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release announcing a strategic partnership between IMPLANET and 8i Robotics Inc. for the clinical evaluation of a surgical robotic system. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general corporate announcement regarding business development and strategic partnerships, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2025-11-13 English
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement from Implanet regarding the successful completion of a capital increase (augmentation de capital). It details the number of shares issued, the price per share, the use of proceeds, the impact on shareholding structure, and the dilution effects. This falls squarely under the category of share issuance and capital changes, as it describes the mechanics and results of a specific equity financing event.
2025-11-03 French
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Capital/Financing Update Classification · 1% confidence The document is a detailed announcement regarding a capital increase (augmentation de capital) with preferential subscription rights (DPS) for the company IMPLANET. It provides specific details on the number of shares, subscription price, subscription period, and the legal framework for the offering. This document is a formal corporate announcement of a capital raising event, which fits the 'Capital/Financing Update' category.
2025-10-09 French
Quarterly financial reporting / Third quarter financial report
Earnings Release Classification · 1% confidence The document is a quarterly revenue announcement for IMPLANET for the period ended September 30, 2025. It provides key financial highlights, revenue breakdowns by activity and geography, and management commentary on growth drivers. It is not a full quarterly report (IR) but rather an initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q3 2025
2025-10-07 English
Information financière trimestrielle / Information financière du troisième trimestre
Earnings Release Classification · 1% confidence The document is a quarterly financial update from Implanet, detailing revenue figures for the third quarter and the first nine months of 2025. It includes tables comparing current performance to the previous year, commentary on regional growth, and strategic outlook. As it provides the initial announcement of quarterly financial results with key highlights rather than a full comprehensive interim report, it is classified as an Earnings Release. Q3 2025
2025-10-07 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release announcing a new exclusive distribution agreement between Implanet and TINAVI Medical Technologies for the TiRobot system. It details the strategic partnership, quotes from management, and provides background information on both companies. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a simple report publication announcement. As it describes a corporate development/partnership, it falls under the general regulatory filing category for corporate announcements.
2025-09-23 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.